News

 

Further Notifications

Here you find all press releases and further notifications, as well as all events of Fraunhofer ITMP.

News / 18.7.2025

Quantum computing in drug discovery at the Fraunhofer ITMP

 

In an increasingly complex and data-driven world, the need for innovative solutions for process optimization is growing. The Hamburg Fraunhofer Institutes (Fraunhofer CML, IAP, IAPT and ITMP) are working together to address relevant industrial applications with quantum computing.

Fraunhofer ITMP uses quantum computing to accelerate fundamental phases of drug research. In a video and a white paper, we explain the basics and how we have used quantum algorithms to better predict the molecular properties of drug precursor molecules.

Press Release / 28.5.2025

Groundbreaking ceremony for new Fraunhofer ITMP building in Penzberg

Today's groundbreaking ceremony for the new Fraunhofer ITMP building in Penzberg marks a significant step forward in immunology and pandemic research. In close collaboration with our partners Roche, LMU Klinikum Munich, and Ludwig Maximilian University (LMU), we are creating a state-of-the-art research center that will develop innovative therapies and diagnostic systems. The new building will be an important location for research in the fight against infectious diseases and will provide space for future-oriented projects that strengthen the health of people and society.

Press Release / 23.5.2025

Fraunhofer ITMP goes SLAS Europe 2025 in Hamburg

 

The SLAS Europe Conference and Exhibition took place in Hamburg for the first time – and Fraunhofer ITMP was there with a diverse program. Dr. Philip Gribbon, site manager of Fraunhofer ITMP Hamburg, opened the conference in his capacity as SLAS president. With presentations, poster sessions, a technology showcase in its own laboratory, and a panel discussion, Fraunhofer ITMP played a key role in shaping the event. Hamburg proved itself to be a strong science location – SLAS will return to the Hanseatic city in 2027.

Research Divisions

Fraunhofer ITMP is organized in 3 cross-site research divisions.

 

Drug Discovery

 

From target to screening to lead optimization and formulation.

 

Preclinical Research

 

Translational cycles and OMICs analyses for characterization of biological mechanisms and novel targets.

 

Clinical Research

 

From „Proof-of-Concept“ to the characterization of established products: “Quality by Design” for successful translation of innovative ideas.

Innovation Areas

Fraunhofer ITMP is optimally interconnected internally as well as externally with other Fraunhofer institutes, universities and industry via the innovation areas. This is the prerequisite for transdisciplinary and flexible cooperation in the areas of new technologies, disease and treatment concepts.

Institute Locations

 

Headquarters of Fraunhofer ITMP

Frankfurt am Main

 

The site has strong expertise in pharmacology and clinical trials in immune-mediated diseases and pain. 

Discovery Research ScreeningPort

Hamburg

 

The site has strong expertise in high-throughput drug discovery (in silico, in vitro screening and drug repurposing) as well as a broad offering in "medical data science".

Translational Neuroinflammation and Automated Microscopy TNM

Göttingen

The site has strong expertise in high- and super-resolution microscopy techniques; as well as neuroinflammation and degenerative diseases.

Immunology and Allergology IA

Berlin


The site has strong expertise in dermatology, allergology, and immunological mast cell-mediated inflammatory diseases of the skin.

Immunology, Infection and Pandemic Research IIP

Penzberg/Munich


The site has strong expertise in developing interventions to address the outbreak of new and spread of existing infectious diseases.